Cosentyx subcutaneous injection 75 mg syringe, manufactured by Novartis Pharma, contains secukinumab (genetical recombination). This subcutaneous injection is used for conditions like plaque psoriasis in pediatric patients. It has YJ code 3999439G3024 and is specified as 150mg 1mL per kit.
Cosentyx subcutaneous injection 75 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).